Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 10,047 | 10,581 | 7,173 | 8,327 | 9,332 |
| Gross Profit | 10,047 | 10,581 | 7,173 | 8,327 | 9,332 |
| Operating Expenses | 26,170 | 24,212 | 23,194 | 20,855 | 20,728 |
| Operating Income | -16,123 | -13,631 | -16,021 | -12,528 | -11,396 |
| Interest Expense | 518 | 542 | 547 | 542 | 446 |
| Other Income | 1,113 | 1,311 | 1,418 | 1,121 | 1,057 |
| Pre-tax Income | -15,528 | -12,862 | -15,150 | -11,949 | -10,785 |
| Net Income Continuous | -15,528 | -12,862 | -15,150 | -11,949 | -10,785 |
| Net Income | $-15,528 | $-12,862 | $-15,150 | $-11,949 | $-10,785 |
| EPS Basic Total Ops | -0.27 | -0.22 | -0.26 | -0.23 | -0.21 |
| EPS Basic Continuous Ops | -0.27 | -0.22 | -0.26 | -0.23 | -0.21 |
| EPS Diluted Total Ops | -0.27 | -0.22 | -0.26 | -0.23 | -0.21 |
| EPS Diluted Continuous Ops | -0.27 | -0.22 | -0.26 | -0.23 | -0.21 |
| EBITDA(a) | $-16,789 | $-13,214 | $-15,602 | $-12,148 | $-11,255 |